Hisamitsu Pharmaceutical Co., Inc.
HTSUY · OTC
2/28/2025 | 2/28/2024 | 2/28/2023 | 2/28/2022 | |
|---|---|---|---|---|
| Revenue | $1 | $142 | $128 | $1 |
| % Growth | -99.3% | 10.4% | 11,804.8% | – |
| Cost of Goods Sold | $0 | $63 | $0 | $0 |
| Gross Profit | $1 | $79 | $1 | $1 |
| % Margin | 58.5% | 55.7% | 0.4% | 58.3% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | -$0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$0 | $66 | $0 | $0 |
| Operating Expenses | $0 | $66 | $0 | $1 |
| Operating Income | $0 | $13 | $12 | $0 |
| % Margin | 12.1% | 9.3% | 9% | 7.8% |
| Other Income/Exp. Net | $0 | $6 | $5 | $0 |
| Pre-Tax Income | $0 | $19 | $16 | $0 |
| Tax Expense | $0 | $5 | $4 | $0 |
| Net Income | $0 | $14 | $0 | $10 |
| % Margin | 13.9% | 9.9% | 0.1% | 895.9% |
| EPS | 0.48 | 0.32 | 0.28 | 0.27 |
| % Growth | 50% | 14.3% | 3.7% | – |
| EPS Diluted | 0.48 | 0.32 | 0.28 | 0.27 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $3 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $5 | $0 | $4 |
| EBITDA | $0 | $24 | $0 | $17 |
| % Margin | 22.5% | 17.2% | 0.1% | 1,604.6% |